On June 1, 2023, Solabia Group, a French pharmaceuticals company, acquired a majority stake in Applechem, Inc., which was founded in 2003 by Samuel Lin within the Enterprise Development Center of the New Jersey Institute of Technology. The deal expands Solabia's portfolio of ingredients and gives it a greater U.S. presence, while generating opportunities in Europe and Asia.
Fasken advised Applechem with a team led by Mike Stephens (M&A), and included Irina Costei (Corporate/Commercial).
Jurisdictions
- Canada
- United States
- France
